Amber Thorne
Nurse Practitioner · Benton, MONPI 1427385376
Payments from drug & device makers
Across 76 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$345
- Axsome Therapeutics, Inc.$214
- Lilly USA, LLC$151
- Johnson & Johnson$141
- AbbVie$100
- Lundbeck LLC$89
- plus $477 from 15 others
What the payments were for
- Food & beverage$1,517100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $345 |
| Axsome Therapeutics, Inc. | 10 | $214 |
| Lilly USA, LLC | 9 | $151 |
| Johnson & Johnson(2 entities) | 7 | $141 |
| AbbVie | 5 | $100 |
| Lundbeck LLC | 4 | $89 |
| Phathom Pharmaceuticals, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $84 |
| Alkermes, Inc. | 2 | $43 |
| Novo Nordisk | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Indivior Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| Amgen | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Eisai Inc. | 1 | $15 |
How this compares
$1,517 in reported general payments places this provider in the 80th percentile of 1,898 nurse practitioner providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $35,448 |
| MounjaroTirzepatide | 13 | $21,392 |
| TrulicityDulaglutide | 13 | $11,468 |
| GemtesaVibegron | 13 | $7,707 |
| Atorvastatin Calcium | 190 | $1,469 |
| Duloxetine Hcl | 77 | $1,443 |
| Gabapentin | 81 | $1,372 |
| Celecoxib | 34 | $1,296 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $1,114 |
| Omega-3 Acid Ethyl Esters | 12 | $1,065 |
| FenofibrateFenofibrate,micronized | 21 | $842 |
| Lisinopril | 69 | $669 |
| Levothyroxine Sodium | 106 | $664 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 60 | $628 |
| Mirtazapine | 27 | $608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $37 | $35,44838 claims |
| Lilly USA, LLCMounjaro, Trulicity | $151 | $32,86026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in Benton
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
- Amanda HumbersFarmington$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.